Altimmune, Inc. (NASDAQ:ALT) is favoured by institutional owners who hold 52% of the company
Key Insights Institutions' substantial holdings in Altimmune implies that they have significant influence over the...
Stay updated with breaking news from Altimmune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Insights Institutions' substantial holdings in Altimmune implies that they have significant influence over the...
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) shot up 4% during trading on Wednesday . The company traded as high as $11.42 and last traded at $11.23. 2,873,800 shares were traded during trading, a decline of 66% from the average session volume of 8,473,833 shares. The stock had previously closed at $10.80. Analyst Upgrades and […]
Shares of Altimmune, Inc. (NASDAQ:ALT – Get Free Report) traded down 4.2% on Tuesday . The stock traded as low as $10.89 and last traded at $10.91. 437,142 shares traded hands during trading, a decline of 95% from the average session volume of 7,999,974 shares. The stock had previously closed at $11.39. Wall Street Analyst […]
Altimmune, Inc. (NASDAQ:ALT – Get Free Report)’s share price was down 5.2% during mid-day trading on Friday . The stock traded as low as $10.67 and last traded at $11.02. Approximately 4,740,645 shares traded hands during mid-day trading, an increase of 35% from the average daily volume of 3,512,153 shares. The stock had previously closed […]
Biotechnology company, Altimmune, Inc. (ALT) continues to gain on Wednesday, despite no corporate-specific news to influence the stock movement. Currently, Altimmune's stock is climbing 3.